ECDC - project HERA, SZÚ

Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic.

Name of the Project: Grant/2021/PHF/23776 - Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic.

Grant Number: ECDC/HERA/2021/004 ECD.12218

Project Duration: from 03/09/2021 to 30/9/2022

Funding: The European Centre for Disease Prevention and Control (ECDC)

Grant: Grant/2021/PHF/23776

The Name of the Call: Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the European Union and European Economic Area

Beneficiary: National Institute of Public Health

Affiliated Entities:

Public Health Institute Ostrava
Public Health Institute Ústí nad Labem
Faculty of Science, Charles University
Institute of Molecular Genetics of the Czech Academy of Sciences
Biology Centre, Czech Academy of Sciences
Centre for Infectious Animal Diseases in Czech University of Life Science Prague
The Institute of Molecular and Translational Medicine

The action „Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic“has received funding from the European Centre for Disease Prevention and Control (ECDC) under GRANT/2021/PHF/23776.

Project Goals:

The general objective of the action is to enhance and/or improve national public health WGS and/or RT-PCR capacity. Results should be directed, tailored and contributing towards the following expected outcomes:

In the short-term, contribution to the establishment of a sustainable, efficient and high capacity WGS and/or RT-PCR infrastructure for national public health microbiology;
In the short/medium-term, contribution to early detection and enhanced monitoring of emergent and known SARS-CoV-2 variants at the national and the EU/EEA levels;
In the medium/long-term, contribution to enhanced genomic-based infectious disease outbreak investigation capacities at regional, national and/or EU/EEA levels;
In the medium/long-term, contribution to enhanced routine genomic-based surveillance of infectious diseases at the regional, national and/or EU/EEA levels, in accordance with the “ECDC strategic framework for the integration of molecular and genomic typing into European surveillance and multi-country outbreak investigations”; and
In the long-term, contribution to enhanced preparedness for timely and effective response in cross-border outbreaks of infectious diseases and pandemics.

Contact Person Responsible for the Application

RNDr. Helena Jiřincová, tel.:267082421, e-mail: helena.jirincova@szucz

Seminars/Workshop	Heslo
Jak se čte genom koronaviru	b%@B6R+X
Výměna zkušeností - příprava knihoven, vyhodnocení vzorků, výpadky primerů v důsledku mutací	Dq7Z=D6b
Fylogenetické analýzy v kostce	1*4SSwf$
Webinář NRL pro chřipku	$2#HyU5t
HERA Odborný bioinformatický seminář
Webinář NRL pro chřipku	!7%j01@=
Webinář NRL pro chřipku	4Jx@L=j.